SavedAdd your journal

Journals / Cukurova Medical Journal / 2017 / Cilt: 42 - Sayı: 3

Malignant peritoneal mesothelioma mimicking ovarian cancer

Over kanseri kliniğini taklit eden malign peritoneal mezotelyoma

Fatih AKTOZ
Elif Taşar KAPAKLI
Günel ZİYADOVA
Oğuzhan KURU
Alp USUBÜTÜN
Zafer Selçuk TUNCER
Pages
579–583
Publication Date
2017-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this case report is to describe the process of differential diagnosis between malign peritoneal mesothelioma and ovarian cancer.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A patient who had ovarian mass, ascites and elevated CA 125 levels was treated with presumptive diagnosis of ovarian cancer.
📊
Key Findings & Data:After pathological examination, she was finally diagnosed as malign peritoneal mesothelioma.
💡
Conclusion & Impact:The aim of this case report is to describe the process of differential diagnosis between malign peritoneal mesothelioma and ovarian cancer.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Mesothelioma · ovarian cancer

Abstract

A patient who had ovarian mass, ascites and elevated CA 125 levels was treated with presumptive diagnosis of ovarian cancer. After pathological examination, she was finally diagnosed as malign peritoneal mesothelioma. Although exposure to asbestos was considered, the diagnosis was not revealed before surgery. Despite similarity of clinical features, ovarian cancer and malign peritoneal mesothelioma have different treatment options and long-term outcomes. The aim of this case report is to describe the process of differential diagnosis between malign peritoneal mesothelioma and ovarian cancer.

Özet

Başlıca bulguları over kaynaklı kitle, asit ve CA 125 yüksekliği olduğu için over kanseri ön tanısı ile cerrahiye alınan 78 yaşındaki olgunun kesin tanısı ancak patoloji raporunun malign mezotelyoma olarak raporlanması üzerine konulabilmiştir. Öyküsünden yıllar önce yaşadığı yer nedeniyle asbeste maruz kaldığı düşünülen hastada kesin tanı ameliyat öncesi konulamamıştır. Over kanseri ile klinik tablo açısından benzerlikler gösterse de tedavileri ve sonuçları açısından aralarında farklılık bulunan bu malign peritoneal mezotelyoma olgusu ayırıcı tanıya yardımcı olması açısından sunulmuştur.

🔖

Cite This Article

AKTOZ, F., KAPAKLI, E. T., ZİYADOVA, G., KURU, O., USUBÜTÜN, A., TUNCER, Z. S. (2017). Malignant peritoneal mesothelioma mimicking ovarian cancer. Cukurova Medical Journal, Cilt: 42 - Sayı: 3, 579–583. https://ajindex.com/articles/143052

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985-90
  2. Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal mesothelioma: a review. Med Gen Med. 2007;9:32
  3. Sugarbaker PH, Turaga KK, Alexander HR, Jr., Deraco M, Hesdorffer M. Management of malignant peritoneal mesothelioma using cytoreductive surgery and perioperative chemotherapy. J Oncol Pract. 2016;12:928-35
  4. Grzankowski KS, Brightwell RM, Kasznica JM, Odusi KO. Malignant peritoneal mesothelioma without asbestos exposure: an ovarian cancer imitator. Gynecol Oncol Rep. 2015;11:10-2
  5. Selikoff IJ, Hammond EC, Seidman H. Latency of asbestos disease among insulation workers in the United States and Canada. Cancer. 1980;46:2736-40
  6. Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI et al. A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Nat Rev Cancer. 2007;7:147-54
  7. Goldberg M, Luce D. The health impact of nonoccupational exposure to asbestos: what do we know? Eur J Cancer Prev. 2009;18:489-503
  8. Hasanoglu HC, Yildirim Z, Ermis H, Kilic T, Koksal N. Lung cancer and mesothelioma in towns with environmental exposure to asbestos in Eastern Anatolia. Int Arch Occup Environ Health. 2006;79:89-91
  9. Shivapurkar N, Wiethege T, Wistuba, II, Milchgrub S, Muller KM, Gazdar AF. Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas. Int J Cancer. 2000;85:743-5
  10. Andersson M, Wallin H, Jonsson M, Nielsen LL, Visfeldt J, Vyberg M et al. Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status. Int J Cancer. 1995;63:330-6
  11. Shivapurkar N, Wiethege T, Wistuba, II, Milchgrub S, Muller KM, Gazdar AF. Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas. Int J Cancer. 2000;85:743-5
  12. Andersson M, Wallin H, Jonsson M, Nielsen LL, Visfeldt J, Vyberg M et al. Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status. Int J Cancer. 1995;63:330-6
  13. Baris I, Simonato L, Artvinli M, Pooley F, Saracci R, Skidmore J et al. Epidemiological and environmental evidence of the health effects of exposure to erionite fibres: a four-year study in the Cappadocian region of Turkey. Int J Cancer. 1987;39:10-7
  14. Alakus H, Yost SE, Woo B, French R, Lin GY, Jepsen K et al. BAP1 mutation is a frequent somatic event in perito